CRNO B — Cereno Scientific AB Income Statement
0.000.00%
Last trade - 00:00- SEK2.25bn
- SEK2.32bn
Annual income statement for Cereno Scientific AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | — |
| Cost of Revenue | |||||
| Gross Profit | -14.3 | -13 | -19.1 | — | — |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 15.7 | 15 | 27.5 | 44.7 | 75.8 |
| Operating Profit | -15.7 | -15 | -27.5 | -44.7 | -75.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -16 | -16.3 | -27.6 | -48.1 | -99.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -16 | -16.3 | -27.7 | -48.1 | -99.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -16 | -16.3 | -27.7 | -48.1 | -99.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -16 | -16.3 | -27.7 | -48.1 | -99.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.223 | -0.154 | -0.201 | -0.206 | -0.353 |
| Dividends per Share |